Maintenance therapy for patients with recurrent or metastatic cervical cancer: A multicentre, cohort study

被引：0
|
作者：
Peng, Chen
Guo, Qiufen
Zhang, Tingting
Chen, Jinlong
Liu, Naifu
Yan, Peile
Lu, Yuanyuan
Ma, Anqun
Lv, Pengzhong
Liu, Jing
Xie, Peng
机构：
[1] Shandong First Med, Shandong Canc Hosp, Jinan, Peoples R China
[2] Shandong First Med Univ & Shandong Acad Med Sci, Shandong Canc Hosp & Inst, Jinan, Peoples R China
[3] Jilin Univ, Dept Gastrointestinal Colorectal & Anal Surg, China Japan Union Hosp, Changchun, Peoples R China
[4] Wannan Med Coll, Dept Radiat Oncol, Affiliated Hosp 1, Wuhan, Peoples R China
[5] Shandong First Med Univ, Dept Thorac Surg, East Hosp, Affiliated Prov Hosp, Jinan, Peoples R China
[6] Shandong First Med Univ, Dept Gynecol, Affiliated Hosp 1, Jinan, Peoples R China
[7] Shandong Prov Qianfoshan Hosp, Jinan, Peoples R China
[8] Sun Yat Sen Univ, Sun Yat Sen Mem Hosp, Dept Radiat Oncol, Guangzhou, Peoples R China
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2023年 / 41卷 / 16期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
e17518
引用
收藏
页数：1
相关论文
共 50 条
  • [11] Clinical Trials of Antiangiogenesis Therapy in Recurrent/Persistent and Metastatic Cervical Cancer
    Alldredge, Jill K.
    Tewari, Krishnansu S.
    ONCOLOGIST, 2016, 21 (05): : 576 - 585
  • [12] Real-world outcomes of first-line maintenance therapy for recurrent or metastatic cervical cancer: A multi-center retrospective study
    Peng, Chen
    Li, Xiaolin
    Tang, Wenjie
    Zhu, Wanqi
    Yan, Peile
    Chen, Jinlong
    Zhang, Xueliang
    Guo, Qiufen
    Wu, Qian
    Wang, Qian
    Liu, Naifu
    Ma, Anqun
    Lu, Yuanyuan
    Lv, Pengzhong
    Liu, Jing
    Xie, Peng
    INTERNATIONAL IMMUNOPHARMACOLOGY, 2024, 129
  • [13] Management of Recurrent or Metastatic Cervical Cancer
    Abu-Rustum, Nadeem R.
    JOURNAL OF THE NATIONAL COMPREHENSIVE CANCER NETWORK, 2023, 21 (5.5): : 576 - 578
  • [14] Metastatic or recurrent cervical cancer/treatment
    Kurtz, Jean-Emmanuel
    D'Hondt, Veronique
    Lecuru, Fabrice
    Lhomme, Catherine
    BULLETIN DU CANCER, 2017, 104 : S39 - S42
  • [15] Chemotherapy for recurrent and metastatic cervical cancer
    Tao, Xia
    Hu, Wei
    Ramirez, Pedro T.
    Kavanagh, John J.
    GYNECOLOGIC ONCOLOGY, 2008, 110 (03) : S67 - S71
  • [16] Chemotherapy for metastatic and recurrent cervical cancer
    Scatchard, Kate
    Forrest, Jennifer L.
    Flubacher, Maxine
    Cornes, Paul
    Williams, Chris
    COCHRANE DATABASE OF SYSTEMATIC REVIEWS, 2012, (10):
  • [17] Advancements in Recurrent and Metastatic Cervical Cancer
    Yu, Steven
    Garcia, Agustin A.
    AMERICAN JOURNAL OF HEMATOLOGY-ONCOLOGY, 2015, 11 (01) : 26 - 31
  • [18] CAMRELIZUMAB MONOTHERAPY OR COMBINATION THERAPY IN PATIENTS WITH RECURRENT OR METASTATIC CERVICAL AND ENDOMETRIAL CARCINOMA:A RETROSPECTIVE STUDY
    Liu, Hong
    Niu, Shuhuai
    Fang, Zhaohui
    Chen, Xi
    Zhang, Qianying
    JOURNAL FOR IMMUNOTHERAPY OF CANCER, 2020, 8 : A109 - A110
  • [19] Efficacy and safety of nivolumab in 100 patients with recurrent or metastatic head and neck cancer - a retrospective multicentre study
    Okamoto, Isaku
    Sato, Hiroki
    Kondo, Takahito
    Koyama, Nobuyuki
    Fushimi, Chihiro
    Okada, Takuro
    Miura, Kouki
    Matsuki, Takashi
    Yamashita, Taku
    Omura, Go
    Tsukahara, Kiyoaki
    ACTA OTO-LARYNGOLOGICA, 2019, 139 (10) : 918 - 925
  • [20] A Retrospective Cohort Study Evaluates Clinical Value of Anlotinib in Persistent, Metastatic, or Recurrent Cervical Cancer After Failure of First-Line Therapy
    Yang, Hui
    Sun, Shaoxing
    Mei, Zijie
    Xiang, Qingming
    Yang, Chunxu
    Chen, Min
    Xie, Conghua
    Zhou, Yunfeng
    Qiu, Hui
    DRUG DESIGN DEVELOPMENT AND THERAPY, 2021, 15 : 4665 - 4674
12345